Specialty Chemicals Expansion And ICT Recovery Will Improve Future Performance

Published
05 Jan 25
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
JP¥4,088.18
12.1% undervalued intrinsic discount
14 Aug
JP¥3,595.00
Loading
1Y
-3.1%
7D
0.3%

Author's Valuation

JP¥4.1k

12.1% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 5.44%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 0.23%

AnalystConsensusTarget has decreased revenue growth from 5.9% to 4.3%, decreased profit margin from 5.2% to 4.5% and increased future PE multiple from 8.7x to 10.6x.

Shared on02 Apr 25
Fair value Increased 6.13%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25
Fair value Decreased 6.46%

Shared on19 Mar 25
Fair value Decreased 0.46%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on12 Mar 25
Fair value Increased 4.77%

AnalystConsensusTarget has increased revenue growth from 4.4% to 5.6%.